Inactive Instrument
Protide Pharmaceuticals, Inc. Stock
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 2010-02-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 886K | |
| +0.88% | +1.18% | +40.64% | +74.91% | 64.69B | |
| +0.10% | +7.34% | +10.24% | +78.09% | 54.78B | |
| +0.28% | +3.46% | +9.64% | +100.82% | 53.49B | |
| -0.11% | +5.54% | +29.05% | +52.15% | 45.98B | |
| -0.96% | +1.18% | +18.73% | +125.82% | 42.94B | |
| -1.05% | +1.41% | +218.54% | +827.77% | 40.08B | |
| -2.26% | -2.06% | +15.38% | +45.14% | 33.52B | |
| +0.22% | -4.77% | +26.59% | +0.55% | 23.97B | |
| +12.46% | +17.03% | +59.09% | +46.70% | 23.67B | |
| Average | +9.32% | +2.22% | +47.55% | +150.22% | 42.57B | |
| Weighted average by Cap. | +0.59% | +2.59% | +44.78% | +151.72% |
Employees
3
